top of page
PARTNERS
EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D).
OUR PARTNERS
Global network for worldwide impact
Lund University, Department of Chemical Engineering
Sweden
Luxembourg Institute of Health (LIH)
Luxembourg
Makerere University
Uganda
Malaria Vaccine Development Program
India
Malawi University of Science and Technology (MUST)
Malawi
Manhiça Health Research Centre (CISM), Manhiça Foundation
Mozambique
Masaryk University, Faculty of Medicine (MUNI)
Czech Republic
Max Planck Institute for Infection Biology
Germany
Medical Center for Translational Research (MTR), Osaka University Hospital
Japan
Medical Research Council (MRC-NIMR)
United Kingdom
Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine (MRCG at LSHTM)
The Gambia
Medical University of Bialystok (UMB)
Poland
Medical University of Vienna
Austria
Medicines & Healthcare Products Regulatory Agency (MHRA) - NIBSC
United Kingdom
Medicines for Malaria Venture (MMV)
Switzerland
Merck Sharp & Dohme (MSD)
The Netherlands
Meyer Chroma Technology APS
Denmark
Microbial Resource Research Infrastructure (MIRRI)
Portugal
Ministry of Health of Israel
Israel
Ministry of Health, Welfare and Sport (VWS)
The Netherlands
Contact us
We'd love to hear from you!
For the latest updates follow EVI on:
bottom of page